Companies / Materials
CF
CF Industries
Fertilizers & Agricultural Chemicals
Fertilizers & Agricultural ChemicalsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health85
Growth50
Profitability86
Cash generation91
Balance sheet95
Dilution control100
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)12.1%Revenue growth (FY)19.3%Revenue CAGR (3y)-14.1%Gross margin38.5%Operating margin32.5%Net margin25.4%Free cash flow margin25.4%R&D / revenue—Stock comp / revenue0.6%Net debt / operating cash flow0.45xCurrent ratio3.37Diluted share count change-10.2%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $6.5B | $11.2B | $6.6B | $5.9B | $7.1B |
| Gross profit | $2.4B | $5.9B | $2.5B | $2.1B | $2.7B |
| Operating income | $1.7B | $5.4B | $2.2B | $1.7B | $2.3B |
| Net income | $1.3B | $3.9B | $1.8B | $1.5B | $1.8B |
| Operating cash flow | $2.9B | $3.9B | $2.8B | $2.3B | $2.8B |
| Capital expenditure | $514M | $453M | $499M | $518M | $950M |
| Free cash flow | $2.4B | $3.4B | $2.3B | $1.8B | $1.8B |
| Stock-based comp | $30M | $41M | $37M | $36M | $45M |
| Buybacks | $539M | $1.3B | $580M | $1.5B | $1.4B |
| Dividends | $260M | $306M | $311M | $364M | $326M |
| Cash | $1.6B | $2.3B | $2.0B | $1.6B | $2.0B |
| Total debt | $3.5B | $3.0B | $3.0B | $3.0B | $3.2B |
| Equity | $3.2B | $5.1B | $5.7B | $5.0B | $4.8B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.